| Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial W Wick, M Platten, C Meisner, J Felsberg, G Tabatabai, M Simon, ... The lancet oncology 13 (7), 707-715, 2012 | 1290 | 2012 |
| Actively personalized vaccination trial for newly diagnosed glioblastoma N Hilf, S Kuttruff-Coqui, K Frenzel, V Bukur, S Stevanović, ... Nature 565 (7738), 240-245, 2019 | 824 | 2019 |
| Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a … U Herrlinger, T Tzaridis, F Mack, JP Steinbach, U Schlegel, M Sabel, ... The lancet 393 (10172), 678-688, 2019 | 523 | 2019 |
| EANO guideline on the diagnosis and management of meningiomas R Goldbrunner, P Stavrinou, MD Jenkinson, F Sahm, C Mawrin, ... Neuro-oncology 23 (11), 1821-1834, 2021 | 500 | 2021 |
| Longitudinal molecular trajectories of diffuse glioma in adults FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ... Nature 576 (7785), 112-120, 2019 | 474 | 2019 |
| Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs E Gulbins, M Palmada, M Reichel, A Lüth, C Böhmer, D Amato, CP Müller, ... Nature medicine 19 (7), 934-938, 2013 | 449 | 2013 |
| MGMT promoter methylation is a strong prognostic biomarker for benefit from dose-intensified temozolomide rechallenge in progressive glioblastoma: the DIRECTOR trial M Weller, G Tabatabai, B Kästner, J Felsberg, JP Steinbach, A Wick, ... Clinical cancer research 21 (9), 2057-2064, 2015 | 390 | 2015 |
| A vaccine targeting mutant IDH1 in newly diagnosed glioma M Platten, L Bunse, A Wick, T Bunse, L Le Cornet, I Harting, F Sahm, ... Nature 592 (7854), 463-468, 2021 | 339 | 2021 |
| Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized … A Omuro, AA Brandes, AF Carpentier, A Idbaih, DA Reardon, ... Neuro-oncology 25 (1), 123-134, 2023 | 313 | 2023 |
| A clinically applicable integrative molecular classification of meningiomas F Nassiri, J Liu, V Patil, Y Mamatjan, JZ Wang, R Hugh-White, AM Macklin, ... Nature 597 (7874), 119-125, 2021 | 309 | 2021 |
| Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation W Wick, C Meisner, B Hentschel, M Platten, A Schilling, B Wiestler, ... Neurology 81 (17), 1515-1522, 2013 | 282 | 2013 |
| Glioma progression is shaped by genetic evolution and microenvironment interactions FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, ... Cell 185 (12), 2184-2199. e16, 2022 | 281 | 2022 |
| Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial B Suchorska, M Weller, G Tabatabai, C Senft, P Hau, MC Sabel, ... Neuro-oncology 18 (4), 549-556, 2016 | 280 | 2016 |
| Mutation of the PTEN (MMAC1) Tumor Suppressor Gene in a Subset of Glioblastomas but not in Meningiomas with Loss of Chromosome Arm 10q J Boström, JMJL Cobbers, M Wolter, G Tabatabai, RG Weber, P Lichter, ... Cancer research 58 (1), 29-33, 1998 | 251 | 1998 |
| DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management F Nassiri, Y Mamatjan, S Suppiah, JH Badhiwala, S Mansouri, S Karimi, ... Neuro-oncology 21 (7), 901-910, 2019 | 233 | 2019 |
| GDF-15 contributes to proliferation and immune escape of malignant gliomas P Roth, M Junker, I Tritschler, M Mittelbronn, Y Dombrowski, SN Breit, ... Clinical cancer research 16 (15), 3851-3859, 2010 | 213 | 2010 |
| CAMTA1 is a novel tumour suppressor regulated by miR‐9/9* in glioblastoma stem cells D Schraivogel, L Weinmann, D Beier, G Tabatabai, A Eichner, JY Zhu, ... The EMBO journal 30 (20), 4309-4322, 2011 | 204 | 2011 |
| Molecular diagnostics of gliomas: the clinical perspective G Tabatabai, R Stupp, MJ Van Den Bent, ME Hegi, JC Tonn, W Wick, ... Acta neuropathologica 120, 585-592, 2010 | 199 | 2010 |
| Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-β-dependent HIF-1α-mediated induction of CXCL12 G Tabatabai, B Frank, R Möhle, M Weller, W Wick Brain 129 (9), 2426-2435, 2006 | 174 | 2006 |
| Aryl hydrocarbon receptor inhibition downregulates the TGF-β/Smad pathway in human glioblastoma cells D Gramatzki, G Pantazis, J Schittenhelm, G Tabatabai, C Köhle, W Wick, ... Oncogene 28 (28), 2593-2605, 2009 | 170 | 2009 |
